期刊文献+

2,2’-联吡啶和三氟甲基修饰β-二酮金属钯(Ⅱ)配合物的合成、表征和体外细胞毒性

Synthesis,characterization and cytotoxicity of palladium(Ⅱ) complexes withβ-diketonate ligands functionalized with trifluoromethyl group and 2,2'-bipyridine
下载PDF
导出
摘要 以取代苯乙酮、三氟乙酸乙酯及2,2’-联吡啶硝酸钯为原料,经Claisen缩合反应和螯合反应得到了系列三氟甲基修饰的β-二酮金属钯(Ⅱ)配合物.配合物结构通过了NMR、ESI-MS、IR及元素分析的表征,用X线单晶衍射测定了配合物3g的晶体结构.用MTT法对产物的体外细胞毒性进行了评价.初步结果表明:所得配合物对MCF-7细胞的毒性明显高于Hela和A549细胞,其中配合物3a对MCF-7的细胞毒性与顺铂相当. A novel series of palladium( II )complexes with β-diketonate ligands functionalized with trif- luoromethyl group and 2,2'-bipyridine(bipy)have been synthesized through a directed self-assembly approach that involves spontaneous deprotonation of the β-diketone ligands in H2O/acetone solution. These complexes have been characterized by elemental analysis,IR,^1H NMR,and HRMS.Crystal strueture of 3g has been determined by X-ray diffraetion analysis.The eytotoxicity was tested by MTT assay.The preliminary results showed that most of the obtained complexes were more toxic against MCF-7 and Hela than A549 eells.The cytotoxicity of complexes 3a is almost equal to that of cisplatin against MCF-7.
出处 《河北大学学报(自然科学版)》 CAS 北大核心 2017年第2期134-140,共7页 Journal of Hebei University(Natural Science Edition)
基金 河北省自然科学基金资助项目(B2015201213) 河北省应用基础研究计划重点基础研究项目(15962602D)
关键词 Pd(Ⅱ)配合物 Β-二酮 三氟甲基 联吡啶 细胞毒性 palladium( Ⅱ) complexes β-diketone trifluoromethyl bipyridine cytotoxieity
  • 相关文献

参考文献1

二级参考文献77

  • 1Rosenberg B, van Camp L, Krigas T. Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature, 1965, 205: 698-699.
  • 2Lévi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, Caussanel JP, Kunstlinger F, Lecouturier S, Descorps-Declere A. A chronopharmacologic phase Ⅱ clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer, 1992, 69: 893-900.
  • 3Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(Ⅳ): an orally active platinum drug. Cancer Res, 1993, 53: 2581-2586.
  • 4Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR. Mechanism-related circumvention of acquired cis-diammine- dichloroplatinum(Ⅱ) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(Ⅳ) dicarboxylates. Cancer Res, 1992, 52: 3857-3864.
  • 5Lovejoy KS, Todd RC, Zhang SZ, McCormick MS, D'Aquino JA, Reardon JT. cis-Diammine(pyridine)chloroplatinum(Ⅱ), a monofunctional platinum(Ⅱ) antitumor agent: uptake, structure, function, and prospects. Proc Natl Acad Sci USA, 2008, 105: 8902-8907.
  • 6Kasparkova J, Suchankova T, Halamikova A, Zerzankova L, Vrana O, Margiotta N, Natile G, Brabec V. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtⅡ chelate complex incorporating the cis-1, 4-diaminocyclohexane carrier ligand. Biochem Pharm, 2009, 79: 552-564.
  • 7Kopf-Maier P, Kopf H. Non-platinum-group metal antitumor agents: history current status and perspectives. Chem Rev, 1987, 87: 1137-1152.
  • 8Coluccia M, Nassi A, Loseto F. Boccarelli A, Mariggio MA, Giordano D, Intini FP, Natile G. A trans-platinum complex showing higher antitumor activity than the cis congeners. J Med Chem, 1993, 36: 510-512.
  • 9Kharatishvili M, Mathieson M, Farrell N. Effects of quinoline as ligand in binding of mononuclear and dinuclear platinum complexes to DNA. Inorg Chim Acta, 1997, 255: 1-6.
  • 10Dreicer R, Propert KJ, Roth BJ, Einhorn LH, Loehrer PJ. Vinblastine ifosfamide, and gallium nitrate: an active new regimen in patients with advanced carcinoma of the urothelium. Cancer, 1997, 79: 110-114.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部